Top Electrophoresis Companies

Electrophoresis Market size was valued at USD 2.72 Billion in 2024 and is poised to grow from USD 2.87 Billion in 2025 to USD 4.47 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026–2033).

The electrophoresis industry is highly competitive, with companies offering advanced technologies designed to meet the needs of research institutes, laboratories and pharmaceutical industries. These companies use innovative electrophoresis solutions to address a variety of applications including proteins research, nucleic acid sequencing and biomarker discovery. The competition is driven by continuous advancements in technology, product diversification, and the need for high throughput and automation in research environments. 'Thermo Fisher Scientific Inc. ', 'Bio-Rad Laboratories, Inc. ', 'GE Healthcare ', 'Agilent Technologies, Inc. ', 'Danaher Corporation ', 'PerkinElmer, Inc. ', 'Merck KGaA ', 'QIAGEN N.V. ', 'Lonza Group Ltd. ', 'Harvard Bioscience, Inc. ', 'Takara Bio Inc. ', 'Promega Corporation ', 'Analytik Jena AG ', 'Sebia Group ', 'Cleaver Scientific Ltd.'

One of the major drivers of the electrophoresis market is increasing generalization and diagnostic accuracy. The separation and analysis of biomolecules such as proteins, nucleic acids, peptides, including gel electrophoresis techniques and capillary electrophoresis play an important role. Advances in proteomics and genomics, which increasingly rely on electrophoretic techniques, are major factors contributing to the expansion of this market by researchers and clinicians to more accurate diagnostic tools and treatments. 

Integration of Automation and Miniaturization: A major factor in the electrophoresis market trend is the incorporation of automation and miniaturization into power circulation systems. Electronic processing offers greater throughput, greater accuracy, and reduced manual labor, making it more attractive to laboratories and clinics that need to process large numbers of samples quickly. Furthermore, miniaturization of the electrodes allows for small portable systems that are cost-effective and suitable for point-of-care testing and field application. 

As per electrophoresis market outlook, North America region dominated the market and accounted for a 35.4% proportion in 2023. This demand is further fueled by advancements in genetic research and the need for accurate disease diagnosis and treatment planning. The electrophoresis market in the U.S. is expected to grow substantially over the forecast period. Owing to the rising incidence of cancer and cardiovascular diseases in the country, along with advancements in molecular diagnostics and personalized medicine, is expected to significantly contribute to the market growth. Further, the increasing adoption of NGS technologies is driving the demand for high-performance electrophoresis instruments and reagents in the country.  Asia Pacific in the market is expected to witness the fastest growth rate of 6.1% CAGR during the forecast period. This market is attributed to increased industry and academic collaboration in countries such as India, China and Japan. For example, in February 2023, a joint organization between the Kyushu Institute of Technology and Tohoku University in Japan developed a new electrophoresis system that combines microfluidic and electrochemical sensing technologies. The system uses a combination of microfluidic techniques and electrodes to enable rapid separation and detection of biomolecules. Furthermore, expanded health coverage and implementation of public health initiatives aimed at reducing application abuse during pregnancy contribute to the electrophoresis market growth in this segment.